CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Apollo Endosurgery, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Apollo Endosurgery, Inc.
1120 South Capital Of Tx Hwy
Building 1 Suite 300
Phone: (512) 279-5100p:512 279-5100 WEST LAKE HILLS, TX  78746-6464  United States Fax: (302) 674-5266f:302 674-5266

This company was Merged or Acquired on 4/4/2023.
This company ceased filing statements with the SEC on 4/14/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202212/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board John R.Barr 64 6/6/2019 3/25/2019
President, Chief Executive Officer, Director Charles S.McKhann 53 3/1/2021 3/1/2021
Chief Financial Officer, Secretary Jeffrey G.Black 53 8/1/2021 8/1/2021
7 additional Officers and Directors records available in full report.

Business Names
Business Name
APEN
Lpath Therapeutics Inc.
Neighborhood Connections, Inc.

General Information
Number of Employees: 281 (As of 12/31/2022)
Outstanding Shares: 57,971,919 (As of 3/15/2023)
Shareholders: 93
Stock Exchange: NASD
Federal Tax Id: 161630142
Fax Number: (302) 674-5266


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024